Promotional graphic for UBC’s Introduction to Biopharmaceutical Manufacturing course, offered in partnership with the UBC-BCIT Biotechnology Program, CIEBH, and CASTL. The program runs through Summer 2025. Lab setting shown in background.
Course

Introduction to Biopharmaceutical Manufacturing 2025

Time limit: 250 days

Spots remaining: 6

$300 Enroll

Full course description

This course provides a comprehensive introduction to biopharmaceutical manufacturing and bioprocessing — the science and engineering that enables the development and production of biologic medicines, including vaccines, cell and gene therapies, and protein-based therapeutics.

Through this course, you will gain an industry-informed overview of the full biomanufacturing process, including:

  • Upstream processing (cell culture and production)

  • Downstream processing (purification and product release)

  • Fill-finish and aseptic processing

  • Regulatory guidelines and Good Manufacturing Practices (GMP)

  • Quality assurance (QA) and process validation

  • Facility design and operational considerations

Designed in partnership with CASTL (Canadian Alliance for Skills and Training in Life Sciences) and based on the internationally recognized NIBRT (National Institute for Bioprocessing Research and Training) curriculum, this course builds the foundational knowledge and technical vocabulary required to understand modern biopharmaceutical production.

You’ll explore the scientific and engineering challenges unique to this field, gain insight into how products move from early development through to commercial manufacturing, and learn about the skills and career opportunities in Canada’s growing biomanufacturing sector.

 

Upon successful completion, students receive a certificate of completion from CASTL powered by NIBRT — recognized within the biopharmaceutical and biotechnology industry.